Last reviewed · How we verify

NCT05394090

The Role of Periodontal Diseases and Stimulation of Saliva Secretion in the Acute Phase of Ischemic Stroke

Completed NA Last updated 27 May 2022
What this trial tests

NA trial testing saliva stimulation in Periodontal Diseases in 50 participants. Completed in 26 April 2021.

Timeline
24 January 2020
Primary endpoint
26 April 2021
26 April 2021

Quick facts

Lead sponsorPomeranian Medical University Szczecin
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment50
Start date24 January 2020
Primary completion26 April 2021
Estimated completion26 April 2021
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Pomeranian Medical University Szczecin

Who can join

Adults 48 to 80, any sex, with Periodontal Diseases or Saliva Altered. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Methods: 100 consecutive patients with their first ever ischemic stroke were enrolled in the study. 56 randomly selected patients were subjected to stimulation of salivation, the remaining patients were not stimulated. The severity of the neurological condition was assessed using the NIHSS scale on days 1, 3 and 7 of stroke. The incidence of periodontal diseases was classified using the Hall's scale in the 1st day of stroke. On days 1 and 7 of stroke, the concentration of IL-1beta, MMP8, OPG and RANKL in the patients' saliva was assessed using the Elisa technique. At the same time, the level of CRP and the number of leukocytes in the peripheral blood were tested on days 1, 3 and 7 of the stroke, and the incidence of upper respiratory and urinary tract infections was assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other Pomeranian Medical University Szczecin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05394090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing